Medicare Drug Price Negotitation Archives

First 10 Medicare Drugs Subject to Price Negotiations Announced

The Biden Administration announced, on August 29, the first ten prescription drugs that will be subject to Medicare price negotiations. The Inflation Reduction Act allows the Medicare Drug Price Negotiation Program to work directly with drug manufacturers to improve the affordability of high-cost name-brand drugs. The ten Medicare Part D …

Revised Guidance on Medicare Drug Price Negotiation Program

As a result of President Biden’s Inflation Reduction Act, Medicare can directly negotiate prices of prescription drugs covered under Medicare Part B or Part D. The initial guidance on the Medicare Drug Negotiation Program was released this past March and requested public comment on its key program elements. Since then, …